ADM Special Populations & Cultural Considerations Flashcards
6 cards from real ADM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 ADM Special Populations & Cultural Considerations flashcards as text
Which organization provides the primary clinical guidelines for managing opioid use disorder during pregnancy in the United States?
Answer: ACOG (American College of Obstetricians and Gynecologists)
ACOG provides evidence-based guidelines for managing opioid use disorder during pregnancy, recommending medication-assisted treatment with methadone or buprenorphine.
What is the recommended first-line pharmacotherapy for opioid use disorder in pregnant women?
Answer: Methadone or buprenorphine-based MAT
Methadone or buprenorphine-based medication-assisted treatment is the recommended first-line approach for OUD in pregnancy, as opioid withdrawal can cause fetal distress.
Current evidence-based management of Neonatal Opioid Withdrawal Syndrome (NOWS) recommends which initial approach?
Answer: Non-pharmacological comfort measures first, with pharmacotherapy added if needed
Current NOWS guidelines support starting with non-pharmacological comfort measures (rooming-in, breastfeeding, reduced stimulation) before escalating to pharmacotherapy.
What most differentiates adolescent patients with SUD from adult patients when considering treatment approaches?
Answer: The adolescent brain is still developing, increasing vulnerability to addiction
The adolescent brain, particularly the prefrontal cortex, is still developing, making youth more vulnerable to addiction and the long-term consequences of substance use.
Which treatment approach does SAMHSA specifically recommend for adolescents with substance use disorders?
Answer: Family-based therapy models such as MDFT or Functional Family Therapy
Family-based therapy models are specifically recommended for adolescents with SUD because family involvement is a critical factor in adolescent recovery.
When treating elderly patients with substance use disorders, which pharmacokinetic factor most requires clinical attention?
Answer: Age-related changes in hepatic metabolism and renal function affect drug dosing
Elderly patients experience age-related reductions in hepatic metabolism and renal function that cause drugs to remain active longer, requiring careful dose adjustments.